Categories: विदेश

UPDATE 1-LifeMD to offer Novo's Ozempic at $499 a month to eligible US cash-paying customers

(Adds background in paragraphs 2-3) Sept 30 (Reuters) – Telehealth firm LifeMD said on Tuesday it would partner with Novo Nordisk to offer its diabetes drug Ozempic at $499 per month to eligible U.S. patients, including insured people whose plans do not cover GLP-1 therapies. Novo offers Ozempic for $499 a month to eligible cash-paying patients via its own pharmacy, NovoCare, and through tie-ups with telehealth platforms. Patients can book virtual visits, complete testing and get medicine shipped with order tracking through LifeMD. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shilpi Majumdar)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Inkhabar webdesk

Share
Published by Inkhabar webdesk

Recent Posts

‘Breakthrough’ finding could transform endometriosis diagnosis

London (PA Media/dpa) - A study has found people with endometriosis have a distinct pattern of…

8 minutes ago

8 जुलाई 2026: भारतीय वॉलीबॉल के लिए बड़ा ऐलान, धीरज मंझेरी और कुलवंत बलयान का नया विज़न

नई दिल्ली, 8 जुलाई: भारतीय वॉलीबॉल एक बार फिर एक महत्वपूण पड़ाव की ओर बढ़…

29 minutes ago

U2 release new arena-ready single and announce a studio album

London (dpa) - Stadium-hopping rock giants U2 have dropped a new radio-ready single and accompanying…

1 hour ago

Most Rolling Stones are in their 80s, but this album doesn't show it

On their new album "Foreign Tongues", the Rolling Stones are brimming with energy and a…

5 hours ago

When your therapist is an alpaca: How helpful are animals in therapy?

Stroking a dog or riding a horse can release oxytocin and ease stress and anxiety.…

8 hours ago

'Jesus Christ Superstar' returns to rock roots with West End revival

By Hanna Rantala LONDON, July 7 (Reuters) - Rock musical "Jesus Christ Superstar" returns to…

10 hours ago